文献速递重症综合管理与镇静镇痛

外泌体在危重症中的作用

Exosomes in Critical Illness.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论循环外泌体水平与危重症发生和临床病程相关,不同表型细胞释放的外泌体功能不同,兼具诊断与治疗功能的外泌体在危重症个体化纳米医学中前景广阔。

本文为综述,通过PubMed检索最新医学文献(含相关文章检索方法),纳入原始研究、综述和会议论文,对经同行评议的科学数据进行详细回顾,总结相关临床前和临床研究。综述聚焦危重症管理前沿、循环外泌体的生物发生/表征与功能、外泌体在急性肺损伤、急性心脏损伤、急性肾损伤和脓毒症中的作用、外泌体分离方案的局限性以及外泌体诊疗应用前景。结论指出循环外泌体水平与危重症的发生和临床病程相关,不同表型细胞释放的外泌体发挥不同功能以保护组织、维持器官功能;兼具诊断与治疗功能的多功能外泌体在危重症患者个体化诊断与治疗的个性化纳米医学方面前景广阔。

要点

  • 循环外泌体水平与危重症的发生和临床病程相关。
  • 不同表型细胞释放的外泌体发挥不同功能,以保护组织、维持器官功能。
  • 外泌体为40-100 nm的细胞释放小囊泡,可经组织间液在细胞间转移蛋白质、脂质、小RNA、信使RNA或DNA。
  • 兼具诊断与治疗功能的多功能外泌体在危重症个体化纳米医学中前景广阔。
  • 外泌体分离方案存在局限性。

研究设计与关键结果

  • 本文为综述,数据来自PubMed检索最新医学文献(包括PubMed「相关文章」检索方法),纳入原始研究、综述和会议论文,对经同行评议的科学数据进行详细回顾,纳入相关临床前和临床研究并总结。
  • 综述内容涵盖:危重症管理前沿;循环外泌体的生物发生、表征与功能;外泌体在急性肺损伤中的作用;外泌体在急性心脏损伤中的作用;外泌体在急性肾损伤中的作用;外泌体在脓毒症中的作用;外泌体分离方案的局限性;外泌体诊疗应用前景。
  • 结论:循环外泌体水平与危重症的发生和临床病程相关;不同表型细胞释放的外泌体发挥不同功能以保护组织、维持器官功能;兼具诊断与治疗功能的多功能外泌体在危重症患者个体化诊断与治疗的个性化纳米医学方面前景广阔。

证据类型、等级与局限

  • 证据类型:综述,纳入原始研究、综述和会议论文,总结相关临床前和临床研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Exosomes are small, cell-released vesicles (40-100 nm in size) with the potential to transfer proteins, lipids, small RNAs, messenger RNAs, or DNA between cells via interstitial fluids. Due to their role in tissue homeostasis, exosomes have emerged as a new type of therapeutic and diagnostic (theranostic) tool in the noninvasive assessment of organ response to injury or treatment and in the development of reliable organ-protective intensive therapy. Our review provides current insights into the role of exosomes in the personalized management of injury and repair responses in critical illness.

DATA SOURCE: Data were obtained from a PubMed search of the most recent medical literature, including the PubMed "related articles" search methodology.

STUDY SELECTION: Articles considered include original articles, review articles and conference proceedings.

DATA EXTRACTION: A detailed review of scientific, peer-reviewed data was performed. Relevant pre-clinical and clinical studies were included and summarized.

DATA SYNTHESIS: Current scientific evidence is focused on the following: 1) Frontiers in the management of critical illness; 2) Biogenesis, characterization, and function of circulating exosomes; 3) The role of exosomes in acute lung injury; 4) The role of exosomes in acute cardiac injury; 5) The role of exosomes in acute kidney injury; 6) The role of exosomes in sepsis; 7) Limitations of exosome isolation protocols; and 8) Perspectives in the theranostic use of exosomes.

CONCLUSIONS: Circulating levels of exosomes are associated with the onset and clinical course of critical illness. Exosomes released from cells with different phenotypes exert different functions in order to protect tissue and preserve organ function. Therefore, multifunctional exosomes with combined diagnostic and therapeutic functions show great promise in terms of personalized nanomedicine for patient-specific diagnosis and treatment of critical illness.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Terrasini N, Lionetti V. Exosomes in Critical Illness. Crit Care Med. 2017. PMID: 28328650. doi:10.1097/CCM.0000000000002328

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。